The health care reform bill to be considered by the House of Representatives (1018-page pdf) includes strict disclosure requirements regarding “financial relationships between manufacturers and distributors of covered drugs, devices, biologicals, or medical supplies under Medicare, Medicaid, or CHIP and physicians and other health care entities” (see “Physician Payments Sunshine Provision” on pages 635 through 653).
All such entities would be required to file annual disclosure reports. Exemptions include investments, goods intended for charity care, short-term equipment loans and payments or transfers of value of less than $5.
